Study presented at SIR shows Surefire Medical technology achieves 80% complete tumor response, effective in downstaging patients to transplant

Trial Comparing the Surefire Infusion System to an end hole catheter finds improved tumor uptake (68%) and reduced non-target embolization (58%) in every patient.

Program supports new fellows in the Interventional Radiology community and highlights relevant clinical experiences with advanced treatment technology

Early observations from the first direct comparison of the Surefire Infusion System vs. a standard end hole catheter in vivo to be presented at GEST